Saint Lukes Hospital

Kansas City, Missouri 64114

5 studies enrolling now · 56 studies all time

What they study most

APC Gene Mutation, AXIN1 Gene Mutation, Acute Coronary Syndrome, Acute Ischemic Stroke, Acute Lung Injury, Acute Respiratory Distress Syndrome, Aortic Stenosis, Severe, Aortic Valve Disease, Aortic Valve Failure, Aortic Valve Stenosis, Arrhythmias, Cardiac, Atrial Fibrillation

Studies at this site

• ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve — Recruiting now
• TVMR With the INNOVALVE System Trial - Early Feasibility Study — Recruiting now
• Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor — Recruiting now
• Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II — Recruiting now
• Patient-Centered Approach for Treatment Decisions in Mitral Valve Prolapse — Recruiting now
• Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier — Recruiting now
• Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation — Running, not enrolling
• Assessment of Combined CCM and ICD Device in HFrEF — Running, not enrolling
• A Study of REC-4881 in Participants With Cancers Which Have an AXIN1 or APC Mutation — Stopped early
• Safety Study of PP-007 in Subjects With Acute Ischemic Stroke — Completed
• Weighted Blankets for IUD Insertion — Enrolling by invitation
• A Study of INCB050465 in Relapsed or Refractory Follicular Lymphoma — Completed
• Multi-arm Optimization of Stroke Thrombolysis — Completed
• Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced, Unresectable Pancreatic Cancer — Completed
• Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator — Completed
• RADIANCE Continued Access Protocol — Running, not enrolling
• PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on Apixaban — Stopped early
• Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) and COAPT CAS — Status unconfirmed
• A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma — Completed
• Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma — Completed
• International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) — Completed
• Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma — Completed
• A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin — Completed
• A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer — Completed
• SUSTAIN-IT: Sustaining Quality of Life of the Aged: Heart Transplant or Mechanical Support? — Completed
• End-Of-Life Decision Making and Preparedness Planning Among Heart Failure Patients Hospitalized for Advanced Disease — Withdrawn before enrolling
• Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI) — Stopped early
• An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI) — Completed
• BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab — Stopped early
• The Effect of Reloading Prasugrel in a Patient Who Has Already Received a Loading Dose (LD) of Clopidogrel — Completed
• POSITIVE Stroke Clinical Trial — Stopped early
• Study to Assess the Safety and Effectiveness of the Penumbra System — Completed
• Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia — Stopped early
• A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2) — Completed
• Safety and Efficacy of Preoperative Antithrombin Supplementation in Patients Undergoing High-Risk Cardiopulmonary Bypass — Completed
• The Asahi Intecc PTCA Chronic Total Occlusion Study — Completed
• CO-OP Trial: Community-based Outreach on Obesity in Pregnancy — Completed
• A Multiple Dose Study Of PF-04950615 (RN316) In Subjects On Maximum Doses Of Statins — Completed
• A Multiple Dose Study of PF-04950615 (RN316) in Subjects on High Doses of Statins — Completed
• ESSENTIAL Trial™ Sham Cross-over — Completed
• The USGI Medical ESSENTIAL Study for Weight Loss — Completed
• One More Magnetic Resonance Imaging — Completed
• AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN — Completed
• Use of Omega-3 Fatty Acids (Fish Oil) in Patients With Chronic Hepatitis C Infection — Withdrawn before enrolling
• MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients — Stopped early
• Cardiogenesis Transmyocardial Revascularization Registry — Completed
• Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome — Completed
• Impact of Physician Directed Education on Patient Compliance With Hepatitis C Therapy — Completed
• ACROSS-Cypher Total Occlusion Study of Coronary Arteries 4 Trial — Completed
• Direct Comparison of 2D Cardiac PET With 3D Cardiac PET — Completed